Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-28T03:45:23.175Z Has data issue: false hasContentIssue false
  • English
  • Français

Remission of positive symptomatology of a schizophrenic psychosis after withdrawing lamotrigine: a case report

Published online by Cambridge University Press:  16 April 2020

W. Stuve ,
A. Wessels  and
L. Timmerman
W. Stuve*
Affiliation:
Adhesie, GGZ-Midden Overijssel, P.O. Box 5003, 7400GC Deventer, The Netherlands
A. Wessels
Affiliation:
Adhesie, GGZ-Midden Overijssel, P.O. Box 5003, 7400GC Deventer, The Netherlands
L. Timmerman
Affiliation:
Adhesie, GGZ-Midden Overijssel, P.O. Box 5003, 7400GC Deventer, The Netherlands
*
*Corresponding author. E-mail address:[email protected] (W. Stuve).
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

GlutamateLamotrigineSchizophrenia
Type
Case report
Information
European Psychiatry , Volume 19 , Issue 1 , January 2004 , pp. 59 - 61
Copyright
Copyright © 2003 European Psychiatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Besag, F.M.C. Lamotrigine in the treatment of epilepsy in people with intellectual disability. Journal of Intellectual Disability Research 1998;42:50–6.Google ScholarPubMed
Bleich, SBleich, KWiltfang, JMaler, MKornhuber, J. Glutaminerge Neurotransmission bei Schizofrenien. Fortschritter der Neurologischer Psychiatrie 2001;2:S56–61 69 Sonderheft.CrossRefGoogle Scholar
Brodie, M.J. Lamotrigine. The Lancet 1992;339:1397–400.CrossRefGoogle ScholarPubMed
Cockerel, O.CMoriarty, JTrimble, MJusemir, J.W.A.SShorvon, S.D. Acute psychological disorders in patients with epilepsy: a nation wide study. Epilepsy Research 1996;25:119–31.CrossRefGoogle Scholar
De Leon, O.AFurmaga, K.M. Effect of lamotrigine treatment in epileptic psychosis. Journal of Clinical Psychopharmacology 1999;19(2):186–7.CrossRefGoogle ScholarPubMed
Erfurth, AWalden, JGrunze, H. Lamotrigine in the treatment of schizoaffective disorder. Neuropsychobiology 1999;38:204–5.CrossRefGoogle Scholar
Goff, D.CCoyle, J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. American Journal of Psychiatry 2001;58:1367–77.CrossRefGoogle Scholar
Kotler, MMatar, M.A. Lamotrigine in the treatment of resistant bipolar disorder. Clinical Neuropharmacology 1998;21:65–7.Google ScholarPubMed
Hertzberg, M.AButterfield, M.IFeldman, M.EBeckham, J.CSutherland, S.MConnor, K.Met al. A Preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biological Psychiatry 1999;45:1226–9.CrossRefGoogle ScholarPubMed
Martin, MMunos-Blanco, J.LLopez-Ariztegui, N. Acute psychosis induced by lamotrigine. Epilepsia 1995;36(Suppl 3):118.Google Scholar
Mechri, ASaoud, MKhiari, Gd'Amato, TDalery, JGaha, Let al. Hypothèse glutaminergique de la schizophrénie: apports de recherches cliniques sur la ketamine. L'Encéphale 2001;28:53–9.Google Scholar
Polselli, G.MPennisi, E.MFigà Talamanca, LRoberti, RFiume Garelli, FBandinelli, P.Let al. Psychotic disorder after lamotrigine. Italian Journal of Neurological Science 1998;19:124–5.CrossRefGoogle ScholarPubMed
Tascedda, FBlom, J.M.CBrunello, NZolin, KGennarelli, MColzi, Aet al. Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. Biological Psychiatry 2001;50:117–22.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.